Rare presentation of MIS in adult COVID patient: Case report and review of literature

Authors

  • Swati Kapoor Internal Medicine Department, Dharamshila Narayana Superspeciality Hospital Delhi, India.
  • Ashutosh Bhardwaj Critical Care Medicine Department, Dharamshila Narayana Superspeciality Hospital Delhi, India.
  • Gitali Bhagawati Microbiology Department, Dharamshila Narayana Superspeciality Hospital Delhi, India.
  • SM Quadri Critical Care Medicine Department, Dharamshila Narayana Superspeciality Hospital Delhi, India.

DOI:

https://doi.org/10.30574/gscarr.2021.9.1.0203

Keywords:

Multi-inflammatory syndrome, Adult COVID-19, Immunoglobulin, Steroids

Abstract

Multi inflammatory syndrome (MIS) is a rare complication associated with covid-19 with few cases reported in pediatric age group. This entity is not well studied in adults. We report a case of a young male presented to us in very critical condition and was diagnosed as a case of MIS-A (Multi Inflammatory Syndrome - Adult). He was successfully treated with intravenous immunoglobulin, steroids and other supportive measure. By correct and timely diagnosis of this entity, one can prevent fatal outcome.

Metrics

Metrics Loading ...

References

Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 1450–1456.

Vogel TP, Top KA, Karatzios C, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021; 39(22): 3037-3049.

Centers for Disease Control and Prevention Health Alert Network (HAN). Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease (COVID-19). 2019.

Centers for Disease Control and Prevention.Multisystem Inflammatory Syndrome in Adults (MIS-A) Case Definition Information for Healthcare Providers.

Fox SE, Lameira FS, Rinker EB, et al. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19 [published online ahead of print July 29, 2020]. Ann Intern

Centers for Disease Control and Prevention. Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C).

Ouldali N, Toubiana J, Antona D, et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. JAMA. 2021; 325(9): 855–864.

Downloads

Published

2021-10-30

How to Cite

Kapoor , S. ., Bhardwaj, A. ., Bhagawati, G. ., & Quadri, S. . (2021). Rare presentation of MIS in adult COVID patient: Case report and review of literature. GSC Advanced Research and Reviews, 9(1), 051–053. https://doi.org/10.30574/gscarr.2021.9.1.0203

Issue

Section

Case Study